T1	Participants 31 48	African Americans
T2	Participants 239 305	Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer
T3	Participants 321 338	African Americans
T4	Participants 630 671	10% of the patients were African American
T5	Participants 865 1016	African Americans versus whites for PemCBev; PemCBev versus PacCBev in African Americans; and academic versus community settings for African Americans.
T6	Participants 1154 1236	Of 939 intent-to-treat (ITT) patients, 94 were African American and 805 were white
T7	Participants 1238 1338	African-American enrollment was uniform across the study sites (median, 1 African American per site)
T8	Participants 1965 1993	African Americans and whites
T9	Participants 2286 2303	African Americans
T10	Participants 2174 2191	African Americans
